2006
DOI: 10.1074/jbc.m603511200
|View full text |Cite
|
Sign up to set email alerts
|

Identification of an Hexapeptide That Binds to a Surface Pocket in Cyclin A and Inhibits the Catalytic Activity of the Complex Cyclin-dependent Kinase 2-Cyclin A

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 45 publications
(34 citation statements)
references
References 47 publications
(47 reference statements)
0
34
0
Order By: Relevance
“…The IC 50 value for the CDK5/cyclin I complex has not been in vitro determined due to cyclin I purification problems. Nevertheless, the mechanism of action of TAT-NBI1 is based on TAT-NBI1 binding to a cyclin groove present in cyclin A that is non-existent in cyclin E. 7 TAT-NBI1 specificity is reflected in the IC 50 s obtained for both complexes (Table S1). The molecular modeling studies of cyclin I described in the bibliography show that cyclin I is a homolog to cyclin E, 37,38 thereby supporting the differential inhibition proposed for TAT-NBI1 of both complexes.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…The IC 50 value for the CDK5/cyclin I complex has not been in vitro determined due to cyclin I purification problems. Nevertheless, the mechanism of action of TAT-NBI1 is based on TAT-NBI1 binding to a cyclin groove present in cyclin A that is non-existent in cyclin E. 7 TAT-NBI1 specificity is reflected in the IC 50 s obtained for both complexes (Table S1). The molecular modeling studies of cyclin I described in the bibliography show that cyclin I is a homolog to cyclin E, 37,38 thereby supporting the differential inhibition proposed for TAT-NBI1 of both complexes.…”
Section: Discussionmentioning
confidence: 99%
“…Both roscovitine 17 and TAT-NBI1 7,8 induced cell death in tumor cell lines. Then we first determined the sensitivity of the LLC-PK1 cell line to these compounds in order to define sublethal concentrations.…”
Section: Cdk Inhibitors Increase Cell Viability In An Ischemia/reperfmentioning
confidence: 99%
See 3 more Smart Citations